Cite
Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.
MLA
Milone, Giuseppe, et al. “Cost-Effectiveness of on-Demand Plerixafor Added to Chemotherapy and Granulocyte-Colony Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma.” Leukemia & Lymphoma, vol. 59, no. 1, Jan. 2018, pp. 42–48. EBSCOhost, https://doi.org/10.1080/10428194.2017.1324161.
APA
Milone, G., Martino, M., Leotta, S., Spadaro, A., Zammit, V., Cupri, A., Avola, G., Camuglia, M. G., Di Marco, A., Scalzulli, P., Morelli, M., Olivieri, A., & Tripepi, G. (2018). Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma. Leukemia & Lymphoma, 59(1), 42–48. https://doi.org/10.1080/10428194.2017.1324161
Chicago
Milone, Giuseppe, Massimo Martino, Salvatore Leotta, Andrea Spadaro, Valentina Zammit, Alessandra Cupri, Giuseppe Avola, et al. 2018. “Cost-Effectiveness of on-Demand Plerixafor Added to Chemotherapy and Granulocyte-Colony Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma.” Leukemia & Lymphoma 59 (1): 42–48. doi:10.1080/10428194.2017.1324161.